P atients with major cerebral artery occlusion represent the most severe cases of ischemic stroke, 1 for whom prompt recanalization would offer an alternative to a very unfavorable outcome. 2 We have previously demonstrated that hyperdense middle cerebral artery sign, which indicates proximal middle cerebral artery occlusion, disappears after intravenous thrombolysis (IVT) in approximately half of cases, and this disappearance, implying vessel recanalization (although not verified as its marker), is associated with lower mortality and better functional outcome.
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September 2013 mechanical elimination of the thrombus) following unsuccessful IVT concept was tested in randomized trials but did not demonstrate its clear advantage. [16] [17] [18] According to the actual IVT protocols, [19] [20] [21] rapid neurological improvement excludes patients from treatment, and substantial improvement after IVT prevents attempts of combined approach. 22, 23 The reason is that early neurological improvement is a predictor of good outcome in stroke, [24] [25] [26] [27] [28] [29] in 1 small study 28 independent from recanalization. The increasing availability of angioimaging techniques raises the question whether recanalization status or change of neurological symptoms is the most relevant information for a decision to proceed with an additional intervention.
We have previously explored the benefit of early (2 hours) neurological improvement in patients with stroke with computed tomographic angiography/magnetic resonance angiography (CTA/MRA)-proven arterial occlusion at baseline. 29 Improvement of any extent was fairly accurate in diagnosing recanalization, but still was strongly predicting favorable 3-month functional outcome. In the present study, we aimed (1) to examine the importance of recanalization at the primary occlusion site in patients with early neurological improvement, and (2) study outcomes of patients who (a) have early NI despite persistent occlusion, and (b) remain with severe neurological deficit despite recanalization of previously occluded vessel.
Methods

Study Design
The present study is based on data of the Safe Implementation of Treatment in Stroke (SITS)-International Stroke Thrombolysis Register. Detailed description of the database is given elsewhere 19 ; also please see http://stroke.ahajournals.com. Ethical approval was obtained in each participating country in accordance with national legislation. Patients were included into the register if they had acute ischemic stroke and received intravenous alteplase 0.9 mg/kg (Actilyse, Boehringer-Ingelheim GMBH), according to the conventional guidelines. Neurological deficit was assessed by National Institute of Health Stroke Scale (NIHSS) before treatment. Computed tomographic (CT) scan was a requirement on admission; other imaging techniques, including CTA, were optional. Only cases with confirmed baseline data and results of admission CT were included into the analysis. Follow-up records included 2-hour and 24-hour NIHSS scores, findings of repeated imaging (performed between 22 and 36 hours after thrombolysis or earlier in case of clinical deterioration), mostly the conventional CT scan, and, in some cases, vascular imaging. All scans were evaluated by local radiologists; presence of dense cerebral artery sign (DAS) on plain CT and cerebral arterial occlusion on CTA/MRA were recorded separately. Neither the site of arterial occlusion nor the grade by any scoring system was specified as the criteria to define the occlusion, and the conclusion was left to the discretion of the local radiologist: in the absence of clear definition, variable CT arterial occlusion in the registry implied proximal occlusion, but its location in arterial segments 2 or 3 was also possible. Functional outcome was estimated at 3 months as a modified Rankin scale score; the main outcome measure was independence, defined as modified Rankin scale 0 to 2 on day 90.
For the purposes of the present study, 2 types of cases were identified. First, patients with baseline arterial occlusion (reported in the SITS database without the specification of occlusion site) documented either by CTA or MRA, who had a follow-up angioimaging between 22 and 36 hours after thrombolysis. Second, patients with dense artery sign (implying, but not limited to dense middle cerebral artery sign, corresponding to M1 occlusion) on admission CT scan, in whom results of follow-up CT scan were also reported. Recanalization (at 24-hour time point) was defined as either absence of vessel occlusion on follow-up 22-to 36-hour CTA/MRA in those with baseline CTA/MRA occlusion, or by resolution of DAS on follow-up 22-to 36-hour CT scan in those with DAS on admission CT scan. Occlusion at 24 hours was defined as persistent occlusion on follow-up 22-to 36-hour CTA/MRA in those recruited by CTA/MRA, or by persistence of DAS on follow-up 22-to 36-hour CT scan in those recruited by admission CT. If both CTA/MRA was done and DAS was reported, evidence from angioimaging was given the priority. If data on follow-up imaging were missing or uncertain, the case was excluded from analysis. Transcranial Doppler findings were scarce because the study was optional in the database, given its limited use in many centers; for this reason, it was not included into selection criteria for the present study.
Neurological improvement was assessed at 2-hour and at 24-hour post-treatment and was defined as improvement by 20% 28, 29 from baseline NIHSS score, as demonstrating the best profile of sensitivity and specificity for the favorable functional outcome in our previous analysis.
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Statistical Analysis
The data set of patients with baseline arterial occlusion was analyzed separately first, and then was merged with the patients identified by DAS, thus was composed the final data set containing both types of cases. To model possible clinical scenarios, we have done cross-tabulation of neurological improvement and recanalization of the previously occluded vessel. Thus, 4 subgroups were allocated in the study population: patients who have both neurological improvement and evidence of vessel recanalization (improvement+recanalization, IR); those who improved despite absence of recanalization (improvement without recanalization, IWR); those who were recanalized but did not improve (recanalization without improvement, RWI); and those who had neither neurological improvement nor recanalization (without improvement and without recanalization, WIWR). Early death (at 2-hour or at 24-hour time point) was incorporated into the calculations as no improvement.
At univariate analysis, we compared the 4 subgroups of patients by baseline data, results of early assessment at 2 hours and at 24 hours, and outcomes. For the comparison of subgroups in univariate testing, χ 2 (with Yates correction for 2×2 tables or Fisher exact test, when appropriate) was used for proportions; Kruskal-Wallis and MannWhitney tests were used for scores and nonparametrically distributed numeric data. Estimation of percentage was based only on those cases in which data were known, excluding missing cases or unknown data. Because a quantity of comparisons have been performed, we set the significance level for univariate testing as P<0.01.
Then, we compared outcomes, computing odds ratios (ORs) for patients with and without neurological improvement, and with and without vessel recanalization. Multiple logistic regression was first run to compute estimates for the known independent predictors of 3-month outcome of stroke IVT: age, baseline NIHSS score, onsetto-treatment time, baseline blood glucose, recanalization, early neurological improvement, and presence of DAS. Except for the DAS, which implies hyperdense middle cerebral artery sign, that is, proximal middle cerebral artery occlusion; no information about the clot size and clot location was available from our data. Second, multiple logistic regression was performed to define adjusted ORs for the 4 subgroups, created by cross-tabulation of neurological improvement and vessel recanalization, for achieving independence at 3 months. In addition, adjusted ORs were calculated separately for the CTA/ MRA-defined population. Statistical analysis was performed with Stata version 12.0 software.
Results
On SITS-International Stroke Thrombolysis Register database state on November 2009, we found 5324 (19% of total patient recorded) cases meeting the inclusion; of those, 991 patients (19% of the data set) were recruited by angioimaging. In the included population, compared with the rest of the SITS population, median age was 68 versus 70 years (P<0.001); median baseline NIHSS score was 16 versus 11 (P<0.001); cerebral infarct present on any admission scan 33% versus 18% (P<0.001; Table I in the online-only Data Supplement, please see http://stroke.ahajournals.com). Recanalization was found in 2592 cases (48.7%), absent in 2412 (45.3%), and was uncertain in 320 cases (6.0%); of those who had follow-up, angioimaging at 22-to 36-hour recanalization occurred in 493 cases (49.7%), was not found in 453 (45.7%), and was uncertain in 45 cases (4.5%).
Of 991 patients with CTA/MRA performed, 925 were assigned to subgroups (66 had missing 2-hour NIHSS assessment); IR was observed in 254 (27%), IWR in 129 (14%), RWI in 231 (25%), and WIWR was observed in 311 patients (34%). Of 5324 patients of the larger data set, 4470 were assigned to subgroups (854 missing): IR 986 (22%), IWR 494 (11%), RWI 1343 (30%), and WIWR 1647 (37%). Early death occurred in 3 of 991 and 39 of 5324 patients at 24 h; at 2 h, no deaths were reported.
Results of univariate comparison of subgroups created by interaction of neurological improvement and recanalization are presented in Table II in the online-only Data Supplement (please see http://stroke.ahajournals.com). Patients who had both neurological improvement at 2 hours and vessel recanalization (IR subgroup), were younger, had, in general, less prevalent stroke risk factors, with more favorable baseline profile (lower onset-to-treatment time, baseline NIHSS score, blood glucose); nevertheless, differences between the subgroups were subtle. Three-month independence rates and mortality are clearly more favorable in patients who improved with recanalization than in those who improved without recanalization (IWR) and in those who recanalized but not improved (RWI; P<0.001 for both independence and mortality). Of importance, >90% of patients who improved at 2 hours and had recanalization demonstrated sustained neurological improvement at 24 hours; in IWR group, 79% still had neurological improvement at 24 h; whereas neurological improvement at 24 hours in the 2 other groups was infrequent (RWI 39%, WIWR 17%; P<0.001).
Results of the multivariable analysis are shown in Table 1 . In the multiple logistic regression model, we calculated estimates for the known predictors of stroke thrombolysis outcome, including age, baseline NIHSS score, baseline blood glucose, recanalization, and early neurological improvement. ORs for achieving independence for the subgroup IR compared with other subgroups are presented in Table 2 . When compared with WIWR as a reference group, ORs for achieving independence for the other subgroups were (in the smaller data set in the larger data set, respectively): IWR, 2.8 (1.6-5.0) and 4.2 (3.2-5.6), P<0.001; RWI, 4.6 (2.8-7.4) and 2.6 (2.1-3.2), P<0.001. Thus, patients who demonstrated both neurological improvement and vessel recanalization have far better chances to achieve independence at 3 months; second, favorable result was found for those who had neurological improvement with persistent occlusion; and third, favorable finding was in the group of recanalized nonresponders.
Distribution of patients by 3-month modified Rankin scale scores in all 4 subgroups is shown in the Figure. 
Discussion
In current clinical practice, early neurological improvement after IVT is widely accepted as an indicator of recanalization, especially if CT or magnetic resonance (MR) angiography is not done. The prognostic role of early neurological improvement is of primary importance because its presence may influence decisions about further evaluation (for instance, repeated vascular imaging) or even further intervention. This issue becomes especially important with the increasing use of bridging approach, when stroke centers send their patients to other hospitals for further endovascular treatment after IVT. The predominant attitude has been neither to consider additional therapeutic intervention, and consequently, nor additional diagnostic imaging, if the patient has significantly improved after IVT. The results of our study may question whether this is an appropriate attitude. Even patients with persistent occlusion may present with neurological improvement already at the 2-hour evaluation. These patients have significantly worse functional outcome at 3 months than those with neurological improvement and recanalization, even after adjustment for other baseline prognostic factors.
Our study has confirmed the independent impact of early NI and recanalization on functional outcome of ischemic stroke, emphasizing the importance of recanalization status in patients both with and without early NI. In the large material 
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of patients with stroke with baseline vessel occlusion, we have shown that the outcome of patients with early neurological improvement after IVT, but without recanalization results in smaller chances to achieve independence within 3 months, compared with those who successfully recanalized (subgroup IR versus IWR). This result may support the active versus conservative strategy for patients with stroke with baseline cerebral artery occlusion, which includes vascular imaging after treatment despite the extent of neurological improvement, and consideration of additional recanalizing interventions in case of persistent occlusion. Obviously, NI alone should not be the only basis for decision making, if any vascular imaging technique is available in the hospital. Moreover, it may be questioned whether rapid improvement of neurological status before IVT, without any objective evaluation of vessel status, should be a factor that excludes patient from candidates for thrombolytic treatment (because it is recommended by the current protocols). Extensive clinical use of vascular imaging in all patients with stroke, which allows to reveal the cerebral artery occlusion at baseline or post-treatment, seems justified. Our study has also demonstrated that functional outcome is moderately improved in patients with evidence of recanalization on 22-to 36-hour follow-up compared with those without recanalization in the absence of neurological improvement after IVT at 2 hours (subgroup RWI, which probably represents late recanalization, versus WIWR). The clinical significance of delayed recanalization for 3-month outcome is supported by the present data in correspondence with previous reports. 30, 31 Based on SITS data, we have no information of timing of recanalization before the follow-up report (22-36 hour) and, hence, cannot distinguish whether the final benefit of recanalization without improvement is based on early Not improved at 2 h, recanalized at 22-36 h (RWI)
In CTA/MRA-defined population (n=991) NS -4.6 2.8-7.4
In angio+DAS-defined population (n=5324) 0.6 0.5-0.8 -2.6 2.1-3.2 CI indicates confidence interval; CTA/MRA, computed tomographic angiography/magnetic resonance angiography; DAS, dense cerebral artery sign; IR, improvement with recanalization, improved at 2 h, recanalized at 22-36 h; IWR, improvement without recanalization, improved at 2 h, occlusion at 22-36 h; and RWI, recanalization without improvement, not improved at 2 h, recanalized at 22-36 h; WIWR, without improvement and without recanalization, not improved at 2 h, occlusion at 22-36 h; and NIHSS, National Institute of Health Stroke Scale.
*Adjusted for age, baseline NIHSS score, baseline blood glucose, DAS on admission CT scan. 32 which demonstrated a significant shift toward lower degrees of disability at 6 months in the IVT-treated patients versus controls, despite the increase of the symptomatic intracranial hemorrhage and early death rates.
Although the benefit of recanalization is well established and confirmed by our data, the optimal method of achieving it is still unclear. The recent publications have not confirmed the benefit of additional mechanical thrombectomy after failed IVT. [16] [17] [18] The largest of those, Interventional Management of Stroke III study, was placed on hold because of low likelihood of finding significant benefit of intervention. However, it is worth noting that recruitment lasted for nearly 6 years (since April 2006), and the protocol permitted the use of any generation embolectomy device as well as IA recombinant tissuetype plasminogen activator; both of these factors must have been leading to a substantial heterogeneity of study population in terms of recanalization timing and success, possibly obscuring the effect of intervention. Further studies of rescue reperfusion techniques are still warranted to define the optimal devices, strategies, and time restrictions.
Our data did not contain any information about the 2 wellestablished predictors of the success of stroke IVT, clot size 33 and clot location 34 (the second factor was addressed only partially by recording of DAS). Other baseline variables are not helpful for prediction of the result of IVT. Estimation of vessel recanalization was made as late as at 22 to 36 hours, whereas no realtime monitoring of vessel status was provided. Theoretically, it could happen that some patients from IWR subgroup may have had reocclusion or after initial successful treatment. From the present data, we can provide neither the reocclusion rate nor the degree of recanalization (complete or partial). These considerations also support the idea that early vascular imaging should be offered to patients with vessel occlusion at baseline even if they improve neurologically after initiation of IVT.
The present study has the other weaknesses related to its observational multicenter design. Interpretation of plain CT and CTA/MRA was not standardized and was performed by local radiologists who were unblinded to the clinical information. Study was performed on the selected population: (a) ≈4% of the whole register was recruited for the angioimaging, which has been increasingly used in many centers during the course of time, but infrequently repeated post-treatment; (b) dense artery sign is highly specific for middle cerebral artery occlusion, although not very sensitive, thus the total cohort constitutes <20%. In some cases, the presence of DAS or presence of occlusion on CTA/MRA could be defined by radiologist as uncertain; these cases were excluded from the analysis, potentially biasing the results. Neither location of occlusion nor the degree of occlusion/recanalization by any grading system was standardized and recorded, possibly creating the heterogeneity of CTA/MRA-defined population by mixing patients with proximal occlusion with occlusion in 2nd or even 3rd vessel segments. Study population was <2 years than the rest of the patients with stroke in the register, and represents the most severe cases, with higher median NIHSS score at baseline, potentially limiting the applicability of our results to mild strokes.
Conclusions
Although causally related, recanalization and early neurological improvement are independently predicting favorable functional outcome after stroke thrombolysis. In patients with neurological improvement after IVT, recanalization highly increases the chances of treatment success. Recanalization is associated with favorable functional outcome also in patients without neurological improvement after IVT. In future evaluations of mechanical thrombectomy and other additional strategies, recanalization should be considered in patients with persisting occlusion after intravenous thrombolysis even in case of significant neurological improvement. Randomized controlled trial is needed to support this hypothesis.
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